Meir Schechter
Ramat Gan, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
New-onset autoimmunity in people living with post-traumatic stress disorder.
Journal: Brain, behavior, and immunity
Published: April 06, 2026
Incidence and clinical manifestations of sudden death in young adults: a two-decade, nationwide, retrospective, cross-sectional study.
Journal: Resuscitation plus
Published: October 18, 2025
Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study.
Journal: Cardiovascular diabetology
Published: August 02, 2025
Mortality, kidney, and safety outcomes with SGLT2 inhibitors versus DPP4 inhibitors in patients with type 2 diabetes treated with systemic glucocorticoids: a real-world exploratory study.
Journal: Diabetes research and clinical practice
Published: March 15, 2025
Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: November 28, 2024
Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Other Glucose-Lowering Agents in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Data.
Journal: Diabetes/metabolism research and reviews
Published: May 25, 2024
Normoalbuminuria-is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta-analysis.
Journal: Diabetes, obesity & metabolism
Published: March 17, 2024
Dapagliflozin and Anemia in Patients with Chronic Kidney Disease.
Journal: NEJM evidence
Published: February 06, 2024
Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease.
Journal: Annals of internal medicine
Published: July 17, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.
Journal: Kidney international
Published: May 17, 2023
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: May 05, 2023
Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: February 27, 2023
Last Updated: 09/26/2026